Targeted tuberculin testing and treatment of latent tuberculosis infection

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Targeted tuberculin testing and treatment of latent tuberculosis infection

Published Date:

June 9, 2000

Status:

current

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-6):1-51.

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. SS-6 ; American journal of respiratory and critical care medicine ; v. 161, no. 4, pt. 2, p. 221-247 ;

[PDF-350.39 KB]

Details:

Corporate Authors:

National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination. . American Thoracic Society. . Centers for Disease Control and Prevention (U.S.)

Keywords:

[+]

Pubmed ID:

10881762

Description:

"This statement provides new recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI) and updates previously published guidelines. This statement is issued in recognition of the importance of these activities as an essential component of the TB Elimination Strategy promoted by the U.S. Public Health Service Advisory Council on the Elimination of Tuberculosis, and reports the deliberations of expert consultants convened by the American Thoracic Society (ATS) and Centers for Disease Control and Prevention (CDC). " - p.

"This report is being published with the permission of the American Thoracic Society and as a courtesy to the MMWR readership. It is an adaptation of a report published in the American Journal of Respiratory and Critical Care Medicine 2000;161:S221--S247. " - p. v

Includes bibliographical references (p. 43-51).

Document Type:

Journal Issue

Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Guidelines and Recommendations
Stephen B. Thacker CDC Library collection

Place as Subject:

United States

Supporting Files:

No Additional Files

Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons : revised recommendations

Corporate Author:

Centers for Disease Control and Prevention (U.S.)

Published:

September 5, 1997

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-15):1-10.

Description:

This report updates and replaces previous recommendations regarding the use of Bacillus of Calmette and Guerin (BCG) vaccine for controlling tuberculosis (TB) in the United States (MMWR 1988;37:663-4, 669-75). Since the previous recommendations were ...

Status:

superseded

File Type:

[PDF - 193.01 KB]

You May Also Like:

Targeted testing and the diagnosis of latent tuberculosis infection and tuberculosis disease

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.

Published:

2008

Series:

Self-study modules on tuberculosis ; module 3

Description:

The Self-Study Modules on Tuberculosis are a series of educational modules designed to provide information about TB in a self-study format. The series consists of a total of nine modules that are separated into two courses. The first course, Modules ...

File Type:

[PDF - 867.67 KB]
Guide for primary health care providers; targeted tuberculin testing and treatment of latent tubersulosis infection

Corporate Author:

National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.; Centers for Disease Control and Prevention (U.S.);

Published:

2005

Description:

CDC and American Thoracic Society published guidelines entitled, Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, in the June 9, 2000 issue of Morbitity and Mortality Weekly Report (MMWR).

File Type:

[PDF - 5.79 MB]
Targeted testing and the diagnosis of latent tuberculosis infection and tuberculosis disease

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.

Published:

2016

Series:

Self-study modules on tuberculosis ; module 3

Description:

In this module, you will learn about targeted testing and the diagnosis of latent tuberculosis (TB) infection (LTBI) and TB disease. Targeted testing is a TB control strategy that is used to identify people who have LTBI and are at high risk for deve...

File Type:

[PDF - 3.57 MB]
Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries

Personal Author:

Cruz, Andrea T.; Starke, Jeffrey R.; Lobato, Mark N.;

Published:

Feb 2014

Source:

Curr Opin Pediatr. 26(1):106-113.

Description:

Purpose of review : The primary purpose is to review guidance on the testing and treatment of latent tuberculosis infection (LTBI) in children. Most children and adults with LTBI have positive tuberculin skin test (TST) or interferon gamma release as...

File Type:

[PDF - 123.82 KB]
Tuberculin Skin Testing in Children

Personal Author:

Reznik, Marina; Ozuah, Philip O.;

Published:

May 2006

Source:

Emerg Infect Dis. 12(5):725-726.

Description:

In 1996, the American Academy of Pediatrics (AAP) recommended targeted tuberculin skin testing (TST) of children while discouraging routine TST of children without risk factors for tuberculosis (TB). Recent studies have provided evidence in support o...

File Type:

[PDF - 62.21 KB]